Pál Rakonczai
Eötvös Loránd Tudományegyetem
H-index: 8
Europe-Hungary
Top articles of Pál Rakonczai
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Cost‐Effectiveness Analysis of Empagliflozin for Treatment of Patients With Heart Failure With Reduced Ejection Fraction in the United States | Journal of the American Heart Association | Odette S Reifsnider Ali Tafazzoli Stephan Linden Jack Ishak Pal Rakonczai | 2024/2/16 |
Cost-effectiveness analysis of empagliflozin in patients with heart failure with reduced ejection fraction in Japan based on the EMPEROR-Reduced trial | Journal of Cardiology | Hiroyuki Tsutsui Hiroyuki Sakamaki Shin-ichi Momomura Yasushi Sakata Yutaro Kotobuki | 2023/6/1 |
A European multinational cost-effectiveness analysis of empagliflozin in heart failure with reduced ejection fraction | The European Journal of Health Economics | Ali Tafazzoli Odette S Reifsnider Leana Bellanca Jack Ishak Marc Carrasco | 2023/12 |
EE151 Health Utilities Associated With Sacituzumab Govitecan (SG) for Treating Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer (MTNBC) | Value in Health | Á Benedict P Rakonczai E Lovato I Proskorovsky Y Xiao | 2022/12/1 |
PCN217 Health State Utility Values of Patients With Locally Advanced or Metastatic Urothelial Carcinoma: Analysis Based on the JAVELIN Bladder 100 Trial | Value in Health | V Kapetanakis P Rakonczai Á Benedict P Cislo J Chang | 2021/6/1 |
Co-Authors
